Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be cited as the primary reason for Louisiana's vaccine policy change by end of 2025?
Economic impact concerns • 25%
Political ideology • 25%
Public health strategy shift • 25%
Other reasons • 25%
Official statements or reports from the Louisiana Department of Health or the Governor's office
Louisiana Bans Vaccine Promotion for COVID, Flu, and Mpox, Citing $100M-$300M Economic Impact
Dec 20, 2024, 05:48 PM
The Louisiana Department of Health has implemented a new policy that prohibits its public health workers from promoting vaccines for COVID-19, influenza, and mpox. According to NPR's investigation, this directive was communicated in meetings held in October and November 2024, with staff being instructed not to encourage the public to get these vaccines through any means, including press releases, interviews, events, presentations, or social media posts. The policy also prevents the department from displaying signs at its clinics indicating the availability of these vaccines. This shift in policy is part of a broader reevaluation of the state's public health priorities, moving away from what the department describes as 'one-size-fits-all paternalistic guidance' towards emphasizing individual choice in vaccination decisions. The change has raised concerns among health department employees about the potential impact on public health, with fears that it could lead to increased deaths from preventable diseases. The estimated annual economic impact on Louisiana due to lost productivity from flu alone is between $100M to $300M. This policy change follows the election of Gov. Jeff Landry, who has been critical of vaccine mandates.
View original story
Stricter vaccine mandates • 25%
Looser vaccine mandates • 25%
No change • 25%
Other changes • 25%
Increase mandates • 25%
Decrease mandates • 25%
No change • 25%
Complete removal of mandates • 25%
Widespread support • 25%
Mixed reactions • 25%
Predominantly negative • 25%
Major public protests • 25%
Majority supportive • 25%
Majority opposed • 25%
Evenly split • 25%
No significant response • 25%
Increased availability • 25%
Government incentives • 25%
Public health campaigns • 25%
Other • 25%
Increase in support • 25%
Decrease in support • 25%
No change • 25%
Mixed opinions • 25%
Majority support changes • 25%
Majority oppose changes • 25%
Public opinion divided • 25%
Insufficient data • 25%
Policy implemented • 25%
Policy blocked by courts • 25%
Policy withdrawn • 25%
No significant action taken • 25%
Safety concerns • 25%
Efficacy concerns • 25%
Public pressure • 25%
Other • 25%
Supportive • 25%
Neutral • 25%
Critical • 25%
No significant response • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
More than $300M • 25%
Less than $100M • 25%
$100M to $200M • 25%
$200M to $300M • 25%